drugset / Trial / NCT00761436
Pilot Study of Safety and Efficacy of Spheramine
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Tolerability and Efficacy of Spheramine will be evaluated after operative implantation (Stereotactic Intrastriatal Implantation) in patients with advanced Parkinson's Disease
Timeline
- Start
- 2000-02-29
- Primary completion
- 2012-05-14
- Completion
- 2012-05-14
Outcome
Outcome not reported
Stopped: “Study was completed, only life long extended follow-up phase was discontinued after 12 years”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spheramine | Cell therapy | — | Other |